医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

PURITO to Launch New Sunscreen Based on Customer Feedback

2022年12月26日 PM11:00
このエントリーをはてなブックマークに追加


 

INCHEON, South Korea

PURITO, a leading eco-friendly K-beauty brand by HINATURE Inc., is launching a new sunscreen.

The product to be released is a sunscreen based on chemical filters (SPF 50+ PA++++), which has been tested for its Sun Protection Factor and UVAPF by several testing institutions both in Korea and overseas.

In addition to the high UV protection level, it contains five different types of ceramides that help strengthen the skin barrier and protect it from environmental stressors.

As PURITO strives to offer innovative solutions for environmental sustainability, the brand is launching sunscreen in upcycled sugarcane packaging, and a 100% PCR tube.

The new sunscreen will be launched under the third “Create Me” project initiated on yearly basis by PURITO to allow the brand to create the product together with the customers.

The main features of the products, its core ingredients, texture, finish, and whether it will be fragranced or not were determined through a consumer survey with the help of more than 6000 participants. The package design and the name of the product were selected by the voting system conducted on the official social media channels of the brand.

Ensuring the product reflects the customers’ needs, PURITO is in the final steps of developing the sunscreen with a silky texture and non-oily finish, that does not cause an eye-stinging sensation and does not leave a white cast on the skin. The new sunscreen will have a lightweight texture that will allow smooth application and quick absorption into the skin.

This product is recommended for all skin types, including oily and combination.

About PURITO

PURITO is an eco-friendly K-beauty brand that is known around the world for its great attention to product efficacy and using the highest-quality ingredients.

View source version on businesswire.com: https://www.businesswire.com/news/home/20221226005001/en/

CONTACT

HINATURE Inc.

Amy Seol, Deputy Manager

+82 70-5227-0945

amy@purito.co.kr

同じカテゴリーの記事 

  • 一份具有里程碑意义的报告证明,大量使用尼古丁不会导致健康问题高发
  • Modalis Therapeutics Reports Data Supporting Development of a Transformative Epigenome Editing Therapeutic, MDL-101: a First-in-Class Epigenome Editing approach for the Treatment of LAMA2-deficient congenital muscular dystrophy (LAMA2-CMD)
  • Galderma Receives Filing Acceptances for Nemolizumab in Prurigo Nodularis and Atopic Dermatitis in Four Additional Countries
  • Inocras Hong Kong Limited, in Collaboration with Cancerinformation.com.hk Charity Foundation and Sponsored by AstraZeneca Hong Kong, Offers Free BRCA or HRD Genetic Testing for Eligible Cancer Patients in Hong Kong and Macau
  • BrainChip Earns Australian Patent for Improved Spiking Neural Network